JP2016536362A5 - - Google Patents

Download PDF

Info

Publication number
JP2016536362A5
JP2016536362A5 JP2016551029A JP2016551029A JP2016536362A5 JP 2016536362 A5 JP2016536362 A5 JP 2016536362A5 JP 2016551029 A JP2016551029 A JP 2016551029A JP 2016551029 A JP2016551029 A JP 2016551029A JP 2016536362 A5 JP2016536362 A5 JP 2016536362A5
Authority
JP
Japan
Prior art keywords
represents hydrogen
alkyl
formula
methyl
chlorine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2016551029A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016536362A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/073760 external-priority patent/WO2015067630A1/de
Publication of JP2016536362A publication Critical patent/JP2016536362A/ja
Publication of JP2016536362A5 publication Critical patent/JP2016536362A5/ja
Withdrawn legal-status Critical Current

Links

JP2016551029A 2013-11-08 2014-11-05 置換されているウラシル類及びそれらの使用 Withdrawn JP2016536362A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13192181.9 2013-11-08
EP13192181 2013-11-08
PCT/EP2014/073760 WO2015067630A1 (de) 2013-11-08 2014-11-05 Substituierte uracile und ihre verwendung

Publications (2)

Publication Number Publication Date
JP2016536362A JP2016536362A (ja) 2016-11-24
JP2016536362A5 true JP2016536362A5 (enExample) 2017-12-07

Family

ID=49582562

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016551029A Withdrawn JP2016536362A (ja) 2013-11-08 2014-11-05 置換されているウラシル類及びそれらの使用

Country Status (6)

Country Link
US (1) US9751843B2 (enExample)
EP (1) EP3066098A1 (enExample)
JP (1) JP2016536362A (enExample)
CN (1) CN105980381A (enExample)
CA (1) CA2929753A1 (enExample)
WO (1) WO2015067630A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3338780A1 (de) 2016-12-20 2018-06-27 Bayer Pharma Aktiengesellschaft Verwendung von chymaseinhibitoren zur behandlung von endometriose, post-operativer fibrose und erkrankungen die durch fibrosebildung gekennzeichnet sind
WO2021000933A1 (zh) * 2019-07-03 2021-01-07 南京明德新药研发有限公司 作为糜酶抑制剂的嘧啶酮类化合物及其应用
WO2022135502A1 (zh) * 2020-12-25 2022-06-30 广东东阳光药业有限公司 多取代的尿嘧啶衍生物及其用途
CN114671878B (zh) * 2020-12-25 2023-08-04 广东东阳光药业有限公司 取代的含氮双环化合物及其用途
CN114685472B (zh) * 2020-12-25 2024-04-26 广东东阳光药业股份有限公司 多取代的尿嘧啶衍生物及其用途
CN117582909B (zh) * 2024-01-19 2024-04-02 天津凯莱英医药科技发展有限公司 一种连续生产5-单硝酸异山梨酯的系统和方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096173A (en) 1977-03-28 1978-06-20 Eli Lilly And Company Chlorinated 1-aminoindane N-methyl transferase inhibitors
DE3912100A1 (de) * 1989-04-13 1990-10-25 Bayer Ag Substituierte uracile, verfahren zu ihrer herstellung und verwendung gegen parasitaere protozoen
DE19834047A1 (de) 1998-07-29 2000-02-03 Bayer Ag Substituierte Pyrazolderivate
DE19834044A1 (de) 1998-07-29 2000-02-03 Bayer Ag Neue substituierte Pyrazolderivate
ATE235487T1 (de) 1998-12-22 2003-04-15 Janssen Pharmaceutica Nv S-oxyde lipide senkende verbindungen
DE19943639A1 (de) 1999-09-13 2001-03-15 Bayer Ag Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften
DE19943636A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943634A1 (de) 1999-09-13 2001-04-12 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943635A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
AR031176A1 (es) 2000-11-22 2003-09-10 Bayer Ag Nuevos derivados de pirazolpiridina sustituidos con piridina
US7160912B2 (en) 2000-12-26 2007-01-09 Dr.Reddy's Laboratories Ltd. Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
DE10102322A1 (de) 2001-01-19 2002-07-25 Merck Patent Gmbh Phenylderivate
DE10110750A1 (de) 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE10110749A1 (de) 2001-03-07 2002-09-12 Bayer Ag Substituierte Aminodicarbonsäurederivate
DE10220570A1 (de) 2002-05-08 2003-11-20 Bayer Ag Carbamat-substituierte Pyrazolopyridine
EP1569905A2 (en) 2002-12-06 2005-09-07 Eli Lilly And Company Inhibitors of monoamine uptake
EP1666067A4 (en) * 2003-08-22 2009-07-22 Teijin Pharma Ltd MEDICAMENT WITH CHYMASE INHIBITOR AS AN ACTIVE SUBSTANCE
DE10342570A1 (de) 2003-09-15 2005-04-14 Bayer Healthcare Ag Verfahren zur Herstellung von 4-(4-Aminophenyl)-3-morpholinon
AR046845A1 (es) 2003-11-21 2005-12-28 Novartis Ag Derivados de 1h-imidazo[4,5-c]quinolina para tratamiento de enfermedades dependientes de las proteino-quinasas
UY29896A1 (es) 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
JO2934B1 (en) * 2006-06-23 2015-09-15 سميث كلاين بيتشام كوربوريشن Prolyl hydroxylase inhibitors
GB0614552D0 (en) 2006-07-21 2006-08-30 Syngenta Ltd Chemical Compounds
GB0622472D0 (en) 2006-11-10 2006-12-20 Addex Pharmaceuticals Sa Novel heterocyclic derivatives
EP2114898A2 (en) 2007-02-16 2009-11-11 Amgen Inc. Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
US7884244B2 (en) 2007-04-12 2011-02-08 Allergan, Inc. Therapeutic fluoroethylcyano guanidines
WO2009049112A1 (en) 2007-10-10 2009-04-16 Smithkline Beecham Corporation Prolyl hydroxylase inhibitors
KR101580482B1 (ko) 2007-11-16 2015-12-28 인사이트 홀딩스 코포레이션 야누스 키나제 억제제로서의 ４－피라졸릴－ｎ－아릴피리미딘－２－아민 및 ４－피라졸릴－ｎ－헤테로아릴피리미딘－２－아민
DE102008030091B4 (de) * 2008-06-25 2011-03-03 Resprotect Gmbh Uracilderivate und deren Verwendung
PL2318006T3 (pl) 2008-08-15 2017-06-30 Nivalis Therapeutics, Inc. Nowe inhibitory pirolowe reduktazy S-nitrozoglutationu jako środki terapeutyczne
ES2614824T3 (es) * 2011-11-14 2017-06-02 Ignyta, Inc. Derivados de uracil como inhibidores de la quinasa axl y c-met
UA112897C2 (uk) 2012-05-09 2016-11-10 Байєр Фарма Акцієнгезелльшафт Біциклічно заміщені урацили та їх застосування для лікування і/або профілактики захворювань

Similar Documents

Publication Publication Date Title
JP2015516000A5 (enExample)
JP2016535769A5 (enExample)
JP2016536362A5 (enExample)
CA2749040A1 (en) Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd
RU2477723C2 (ru) Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
IL276946B (en) Antiproliferative compounds and methods of use
CA2709786A1 (en) 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof
HRP20220899T1 (hr) Spojevi policikličkog karbamoilpiridona i njihova farmaceutska uporaba
HRP20150341T1 (hr) Heterocikliäśki supstituirani spojevi arila kao inhibitori hif
JP2016540742A5 (enExample)
JP2017515844A5 (enExample)
JP2017526701A5 (enExample)
JP2019522628A5 (enExample)
JP2010501478A5 (enExample)
JP2016518434A5 (enExample)
JP2010539110A5 (enExample)
JP2016525136A5 (enExample)
WO2016097869A4 (en) Fused ring heteroaryl compounds and their use as trk inhibitors
ME02809B (me) Ariltriazoloni spojeni sa bis-arilom i njihova upotreba
JP2011506501A5 (enExample)
JP2005509038A5 (enExample)
JP2013533253A5 (enExample)
JP2020523388A5 (enExample)
JP2012509263A5 (enExample)
JP2005505618A5 (enExample)